SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
355.50    5.50 (1.57%)
Bid:
354.00
Ask:
358.00
Spread: 4.00 (1.13%)
Market Cap: £1.82b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

30 May 2024 14:55

RNS Number : 4552Q
Caledonia Investments PLC
30 May 2024
Ā 

Caledonia Investments plc

Notification of transactions of persons discharging managerial responsibilities ("PDMR") or persons closely associated with them ("PCA")

Ā 

Pursuant to the requirements of the Market Abuse Regulation, Caledonia Investments plc ("Caledonia" or the "Company") announces that on 28 May 2024 the following nil-cost options over ordinary 5p shares in Caledonia were granted to executive directors under the Caledonia Investments 2020 Performance Share Scheme (the "PSS") and in respect of compulsory deferral of bonus under the Caledonia Investments 2020 Deferred Bonus Plan (the "DBP"). The Company's share price used to determine the number of PSS awards and DBP awards was 3410p.

Ā 

Executive Director

No. of shares over which PSS nil-cost options granted

No. of shares over which DBP nil-cost options granted

J M B Cayzer-Colvin

17,617

1,214

M S D Masters

21,620

2,979

R W Memmott

19,223

Nil

Subject to the rules of the PSS, nil-cost options are exercisable between three and ten years after the date of grant. Performance is measured over three years for one-third of the PSS awards which are subject to a post-vesting holding period, on an after-tax basis, of two years. The remaining two-thirds of the awards are subject to performance over five years.

Subject to the rules of the DBP, deferred share awards vest after a three-year retention period.

Ā 

The total number of shares held under option by the above-named executive directors of Caledonia under the Company's performance share schemes following these nil-cost option grants are as follows:

Ā 

Executive Director

Total no. of shares held under option under PSS

Total no. of shares held under option under DBP

J M B Cayzer-Colvin

97,000

10,311

M S D Masters

92,377

11,442

R W Memmott

36,796

Nil

Ā 

Further information required by the Market Abuse Regulation in relation to these transactions is set out in the appendix below.

Ā 

Enquiries:

Richard Webster

Company Secretary

Tel: + 44 20 7802 8080

Ā 

30 May 2024

Ā 

Ā 

APPENDIX

Ā 

1

Ā 

Details of the person discharging managerial responsibilities / person closely associated

Ā 

a)

Ā 

Name

Ā 

James Michael Beale Cayzer-Colvin

2

Ā 

Reason for the notification

Ā 

a)

Ā 

Position/status

Ā 

Executive Director

b)

Ā 

Initial notification /Amendment

Ā 

Initial notification

3

Ā 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Ā 

a)

Ā 

Name

Ā 

Caledonia Investments plc

b)

Ā 

LEI

Ā 

2138002FX1MYCA5ZZH32

4

Ā 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Ā 

a)

Ā 

Description of the financial instrument, type of instrument

Ā 

Identification code

Ā 

Ordinary 5p shares

Ā 

Ā 

Ā 

GB0001639920

b)

Ā 

Nature of the transaction

Ā 

Ā 

Grant of nil-cost options over ordinary 5p shares under:

(1) the Caledonia Investments 2020 Performance Share Scheme ("PSS")

Ā 

(2) the Caledonia Investments 2020 Deferred Bonus Plan ("DBP")

Ā 

c)

Ā 

Price(s) and volume(s)

Ā 

Ā 

Ā 

Description

Price(s)

Ā 

Volume(s)

Grant of PSS award

Ā 

Ā£0.00

Ā 

17,617

Grant of DBP award

Ā 

Ā£0.00

1,214

d)

Ā 

Aggregated information

Ā 

- Aggregated volume

Ā 

- Price

Ā 

Ā 

Ā 

18,831

Ā 

Nil

e)

Ā 

Date of the transaction

Ā 

28 May 2024

f)

Place of the transaction

Outside a trading venue

Ā 

Ā 

1

Ā 

Details of the person discharging managerial responsibilities / person closely associated

Ā 

a)

Ā 

Name

Ā 

Mathew Simon Dexter Masters

2

Ā 

Reason for the notification

Ā 

a)

Ā 

Position/status

Ā 

Director/Chief Executive Officer

b)

Ā 

Initial notification /Amendment

Ā 

Initial notification

3

Ā 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Ā 

a)

Ā 

Name

Ā 

Caledonia Investments plc

b)

Ā 

LEI

Ā 

2138002FX1MYCA5ZZH32

4

Ā 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Ā 

a)

Ā 

Description of the financial instrument, type of instrument

Ā 

Identification code

Ā 

Ordinary 5p shares

Ā 

Ā 

Ā 

GB0001639920

b)

Ā 

Nature of the transaction

Ā 

Ā 

Grant of nil-cost options over ordinary 5p shares under:

Ā 

(1) the Caledonia Investments 2020 Performance Share Scheme ("PSS")

Ā 

(2) the Caledonia Investments 2020 Deferred Bonus Plan ("DBP")

Ā 

c)

Ā 

Price(s) and volume(s)

Ā 

Ā 

Ā 

Ā 

Description

Price(s)

Ā 

Volume(s)

Grant of PSS award

Ā 

Ā£0.00

Ā 

21,620

Grant of DBP award

Ā 

Ā£0.00

2,979

Ā 

Ā 

d)

Ā 

Aggregated information

Ā 

- Aggregated volume

Ā 

- Price

Ā 

Ā 

Ā 

24,599

Ā 

Nil

e)

Ā 

Date of the transaction

Ā 

28 May 2024

f)

Place of the transaction

Outside a trading venue

Ā 

Ā 

1

Ā 

Details of the person discharging managerial responsibilities / person closely associated

Ā 

a)

Ā 

Name

Ā 

Robert William Memmott

2

Ā 

Reason for the notification

Ā 

a)

Ā 

Position/status

Ā 

Executive Director/Chief Financial Officer

b)

Ā 

Initial notification /Amendment

Ā 

Initial notification

3

Ā 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Ā 

a)

Ā 

Name

Ā 

Caledonia Investments plc

b)

Ā 

LEI

Ā 

2138002FX1MYCA5ZZH32

4

Ā 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Ā 

a)

Ā 

Description of the financial instrument, type of instrument

Ā 

Identification code

Ā 

Ordinary 5p shares

Ā 

Ā 

Ā 

GB0001639920

b)

Ā 

Nature of the transaction

Ā 

Ā 

Grant of nil-cost options over ordinary 5p shares under the Caledonia Investments 2020 Performance Share Scheme ("PSS")

Ā 

c)

Ā 

Price(s) and volume(s)

Ā 

Ā 

Ā 

Ā 

Description

Price(s)

Ā 

Volume(s)

Grant of PSS award

Ā 

Ā£0.00

Ā 

19,223

Ā 

Ā 

d)

Ā 

Aggregated information

Ā 

- Aggregated volume

Ā 

- Price

Ā 

Ā 

Ā 

n/a

Ā 

n/a

e)

Ā 

Date of the transaction

Ā 

28 May 2024

f)

Place of the transaction

Outside a trading venue

Ā 

Ā 

Ā 

Ā 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
DSHBXGDUXUXDGSG
Date   Source Headline
14th Nov 20254:21 pmRNSHolding(s) in Company
14th Nov 20257:00 amRNSTransaction in Own Shares
11th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20251:27 pmRNSNet Asset Value(s)
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 20257:00 amRNSTotal Voting Rights
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20254:08 pmRNSDirector/PDMR Shareholding
27th Oct 20257:00 amRNSTransaction in Own Shares
23rd Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20257:00 amRNSTransaction in Own Shares
20th Oct 20257:00 amRNSTransaction in Own Shares
17th Oct 20257:00 amRNSTransaction in Own Shares
16th Oct 20257:00 amRNSTransaction in Own Shares
15th Oct 20257:00 amRNSTransaction in Own Shares
14th Oct 20257:00 amRNSTransaction in Own Shares
13th Oct 20257:00 amRNSTransaction in Own Shares
10th Oct 20257:00 amRNSTransaction in Own Shares
9th Oct 20257:00 amRNSTransaction in Own Shares
8th Oct 20257:00 amRNSTransaction in Own Shares
7th Oct 20257:00 amRNSNet Asset Value(s)
1st Oct 20257:00 amRNSTotal Voting Rights
29th Sep 20252:55 pmRNSDirector/PDMR Shareholding
26th Sep 20257:00 amRNSTransaction in Own Shares
25th Sep 20257:00 amRNSTransaction in Own Shares
19th Sep 20254:34 pmRNSDirector/PDMR Shareholding
18th Sep 20253:23 pmRNS-RUpdate from QuotedData
4th Sep 20259:31 amRNSNet Asset Value(s)
3rd Sep 20257:00 amRNSTransaction in Own Shares
2nd Sep 20259:31 amRNSAgreement to sell interest in Stonehage Fleming
2nd Sep 20257:00 amRNSTransaction in Own Shares
1st Sep 20257:00 amRNSTotal Voting Rights
1st Sep 20257:00 amRNSTransaction in Own Shares
29th Aug 20257:00 amRNSTransaction in Own Shares
28th Aug 20255:01 pmRNSDirector/PDMR Shareholding
28th Aug 20257:00 amRNSTransaction in Own Shares
27th Aug 20257:00 amRNSTransaction in Own Shares
13th Aug 20257:00 amRNSTransaction in Own Shares
12th Aug 20257:00 amRNSTransaction in Own Shares
11th Aug 20257:00 amRNSTransaction in Own Shares
8th Aug 20257:00 amRNSTransaction in Own Shares
7th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20259:47 amRNSNet Asset Value(s)
6th Aug 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.